All News

Prolonged "air hunger" induced during mechanical ventilation for severe COVID-19 infection can be eliminated by a change in standard of care, a new paper suggests.

Continued mepolizumab treatment yielded clinical benefits in patients with severe eosinophilic asthma, suggests a new study being presented at the upcoming American Thoracic Society 2020 Virtual International Conference.

Get the latest data on confirmed cases, recoveries, and more with our daily COVID-19 update.

Researchers from the University of Pennsylvania found patients who were prescribed higher dosages were more likely to refill their opioid prescriptions.

VIDEO: Kieran Docherty, MBChB, discusses results of the DAPA-HF analysis on the impact of background T2D therapy on clinical outcomes in patients with T2D and HFrEF.

It’s a good idea to wear a mask while exercising and to thoroughly clean shoes to avoid bringing COVID-19 into the home, correct? Here are a few new myths your patients may be sharing.

Physicians shared what ancillary services they provided most often in 2019 and how they earned secondary income, in the Medical Economics 91st annual Physician Report.

Get the latest data on confirmed cases, recoveries, and more with our daily COVID-19 update.

Major companies like Moderna and AstraZeneca have launched clinical trials for potential COVID-19 vaccines. Which ones should be on the PCP’s radar? We’ve got answers.

ADA 2020. Average A1c for a recent young cohort with type 2 diabetes was 8.5%, according to research presented at the ADA Virtual Scientific Sessions.

The latest COVID-19 data on confirmed cases, recoveries, and more from the Johns Hopkins COVID-19 interactive map.

New data from the Diabetes Prevention Outcomes Study shows persistent reduction of type 2 diabetes development over 22-year average follow-up.

Physicians’ CKD awareness in T2D is linked with CKD severity, suggests a new study presented this week at the American Diabetes Association’s 80th Virtual Scientific Sessions.

New research from the University of Oxford found dexamethasone reduced death by one-third in severely ill patients hospitalized with COVID-19.

VIDEO: Silvio Inzucchi, MD, discusses results of a prespecified analysis of the DAPA-HF trial, which found that dapagliflozin reduced new onset diabetes by 32% in patients with heart failure.

The FDA revoked the emergency use authorization that allowed the malaria drug to be used to treat hospitalized patients with COVID-19.

There are now >8 million confirmed cases of COVID-19 globally. Plus more data from the Johns Hopkins COVID-19 interactive map you should know about today.

ADA 2020: Glycemic control was worse for black patients who experienced hurried interaction with healthcare providers than for those who did not, a new study reports.